🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Nureca Ltd (NURE)

NSE
Currency in INR
Disclaimer
271.65
-0.15(-0.06%)
Closed

NURE Comments

fake bounce, will again start downward journey from Monday.
bakwas
fake bounce, will downward journey from Monday
will go down below IPO price
sales .............sales..................sales...........
Kal opening 1600 plus
SirI bought NURECA @2096Shell I hold for long term Or can I sell.Please guide me Thank you sir 🙏
HOLD AND NOW ADD MORE .. ONE YEAR TGT 3000 ..
The Nureca has little access to the largest market for nutritional supplements with lower sales through hospitals and pharmacy. Most dependent on e- retail platform and third party vendors.It kicked off nice against IPO price of 400. Dr. Trust in known brand name under which it has most products. I beileve it has potenital but in near future term it may go below the IPO OFFER price. New investors should wait till such time ...
In year 2022 this price will up to 1000Rs
In year 2022 this price will around 3000 Rs
bulish
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.